Reaktionsgleichung
[N:1]1[C:11]2[C:10](=O)[CH2:9][CH2:8][C:7](=[O:13])[NH:6][C:5]=2[CH:4]=[CH:3][CH:2]=1.Cl.[I:15][C:16]1[CH:21]=[CH:20][C:19]([NH:22][NH2:23])=[CH:18][CH:17]=1.[K+].[Br-]>>[I:15][C:16]1[CH:21]=[CH:20][C:19]([NH:22][N:23]=[C:10]2[CH2:9][CH2:8][C:7](=[O:13])[NH:6][C:5]3[CH:4]=[CH:3][CH:2]=[N:1][C:11]2=3)=[CH:18][CH:17]=1Komponenten
4
Versuchsvorschrift
Prepared according to general procedure A from 176 mg (1.0 mmol) 5H-pyrido[3,2-b]azepine-6,9(7H,8H)-dione and 257 mg (1.5 mmol) (4-iodophenyl)hydrazine hydrochloride. Recrystallization from ethanol afforded an orange solid. Yield: 248 mg (63%); m.p. 204-205° C.; IR (KBr): 3211 cm−1 (NH), 2964/2900 cm−1 (CH-aliph.), 1691 cm−1 (C═O); 1H-NMR (DMSO-d6, 400 MHz): δ (ppm)=2.55-2.59 (m, 2H, azepine-CH2, part of AA′XX′-system), 3.01-3.04 (m, 2H, azepine-CH2, part of AA′XX′-system), 7.02-7.06 (m, 2H, arom. H), 7.37-7.44 (m, 2H, arom. H), 7.50-7.54 (m, 2H, arom. H), 8.41 (dd, 1H, 4.5/1.7 Hz, arom. H), 9.51 (s, 1H, NH), 9.82 (s, 1H, NH); C15H13IN4O (392.20).
Aufarbeitung
- customPrepared
- customRecrystallization from ethanol
- customafforded an orange solid
Quellen und Nachweise
- ORD-Eintrag
- ord-e1768963281241798e3ef96c359995b7
- Quelldatensatz
- uspto-grants-2011_06
- Patentnummer
- US07968535B2
Verknüpfte Notizen
Wird geladen…